
Jade Biosciences, Inc.: updates and filings
Price
$15.31
November 20, 2026Market cap $1.1B
What Ploutos Investor adds for Jade Biosciences
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
September 2026
August 2026
June 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Results of operationsForm8-K
- Oct 28, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 30, 2026Other material eventsForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 10, 2026Results of operationsForm8-K
- Jul 17, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 8, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 1, 2026Material agreement enteredForm8-K
- Jun 26, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jun 11, 2026Amended articles or bylaws, shareholder voteForm8-K
- Jun 9, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jun 5, 2026Additional annual meeting materialFormDEFA14A
- Jun 4, 2026Other material eventsForm8-K
- Jun 1, 2026Regulation FD disclosure, other material eventsForm8-K
- May 15, 2026FilingFormEFFECT
- May 15, 2026FilingFormEFFECT
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | 8-K | Results of operations | Document |
| Oct 28, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 30, 2026 | 8-K | Other material events | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Jul 17, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 8, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 1, 2026 | 8-K | Material agreement entered | Document |
| Jun 26, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jun 11, 2026 | 8-K | Amended articles or bylaws, shareholder vote | Document |
| Jun 9, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jun 5, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jun 4, 2026 | 8-K | Other material events | Document |
| Jun 1, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 15, 2026 | EFFECT | Filing | Document |
| May 15, 2026 | EFFECT | Filing | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 8, 2020.
The full analysis
What do Jade Biosciences's filings show?
The filings are where every one of Jade Biosciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.